title: Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models.
abstract: Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a novel approach for cancer therapy. In this study we describe for the first time the use of dynamic boolean modeling for tumor growth prediction of vaccinia virus GLV-1h68-injected canine tumors including canine mammary adenoma (ZMTH3), canine mammary carcinoma (MTH52c), canine prostate carcinoma (CT1258), and canine soft tissue sarcoma (STSA-1). Additionally, the STSA-1 xenografted mice were injected with either LIVP 1.1.1 or LIVP 5.1.1 vaccinia virus strains.   Antigen profiling data of the four different vaccinia virus-injected canine tumors were obtained, analyzed and used to calculate differences in the tumor growth signaling network by type and tumor type. Our model combines networks for apoptosis, MAPK, p53, WNT, Hedgehog, TK cell, Interferon, and Interleukin signaling networks. The in silico findings conform with in vivo findings of tumor growth. Boolean modeling describes tumor growth and remission semi-quantitatively with a good fit to the data obtained for all cancer type variants. At the same time it monitors all signaling activities as a basis for treatment planning according to antigen levels. Mitigation and elimination of VACV- susceptible tumor types as well as effects on the non-susceptible type CT1258 are predicted correctly. Thus the combination of Antigen profiling and semi-quantitative modeling optimizes the therapy already before its start.
authors.affiliation: a Department of Biochemistry; Theodor-Boveri-Institute; University of Würzburg; Würzburg, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Cecil
authors.forename: Ivaylo
authors.initials: I
authors.lastname: Gentschev
authors.forename: Marion
authors.initials: M
authors.lastname: Adelfinger
authors.forename: Ingo
authors.initials: I
authors.lastname: Nolte
authors.forename: Thomas
authors.initials: T
authors.lastname: Dandekar
authors.forename: Aladar A
authors.initials: AA
authors.lastname: Szalay
mesh_terms: D000818:Animals; D002460:Cell Line; D045744:Cell Line, Tumor; D004285:Dogs; D008954:Models, Biological; D050130:Oncolytic Virotherapy; D050504:Oncolytic Viruses / Q000502:physiology*; D014616:Vaccinia virus / Q000502:physiology*; D023041:Xenograft Model Antitumor Assays
keywords: CT1258; MTH52c; STSA-1; ZMTH3; canine xenografts; oncolytic virus; semi-quantitative boolean modeling